This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO)
Clinical trial NCT03780608 · UNKNOWN
Trial details
- NCT number
- NCT03780608
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-30
- Primary completion
- 2022-12-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.